Skip to main content

Table 1 Risk factors and demographic data of controls and ovarian cancer patients

From: Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer

 

Cases n = 50%

Control n = 50%

p-value

Age (years)

X ± SD

56.3 ± 6.6

 

54.8 ± 6.9

  

 ≤ 50

20

40.0%

16

32.0%

 

 > 50

30

60.0%

34

68.0%

0.28

Residence

Rural

29

58%

30

60%

0.83

Urban

21

42%

20

40%

 

Family history

 − ve

41

82.0%

   

 + ve

9

18.0%

   

Menopausal status

Pre

22

44%

30

60%

0.1

Post

28

56%

20

40%